Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Patients”

3,757 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,757 results

Not applicableUnknownNCT04836351
What this trial is testing

Rehabilitation for Patients With Persistent Symptoms Post COVID-19

Who this might be right for
Covid19
Western Norway University of Applied Sciences 20
Not applicableStudy completedNCT05317962
What this trial is testing

COVID-19 Echo Study

Who this might be right for
Covid-19Cardiac Disease
London North West Healthcare NHS Trust 251
Not applicableStudy completedNCT04393805
What this trial is testing

Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto

Who this might be right for
COVID-19Hypercoagulability
Quovadis Associazione 744
Not applicableStudy completedNCT05977166
What this trial is testing

Hyperbaric on Pulmonary Functions in Post Covid -19 Patients.

Who this might be right for
Post COVID-19 Patients
Cairo University 72
Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Testing effectiveness (Phase 2)UnknownNCT04404218
What this trial is testing

The Açaí Berry COVID-19 Anti-Inflammation Trial

Who this might be right for
COVID
University Health Network, Toronto 480
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Not applicableLooking for participantsNCT06585254
What this trial is testing

TVNS in Long COVID-19

Who this might be right for
Long COVIDChronic Fatigue Syndrome
Icahn School of Medicine at Mount Sinai 50
Not applicableStudy completedNCT04800731
What this trial is testing

Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19

Who this might be right for
LymphopeniaCovid19Older People
Universitair Ziekenhuis Brussel 227
Not applicableUnknownNCT04910360
What this trial is testing

Embolism in COVID-19 Positive Patients

Who this might be right for
COVID-19 PneumoniaEmbolismGenetic Predisposition
Afyonkarahisar Health Sciences University 50
Not applicableStudy completedNCT05685888
What this trial is testing

Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transplantation

Who this might be right for
Organ TransplantationCOVID-19
First Affiliated Hospital Xi'an Jiaotong University 2,000
Testing effectiveness (Phase 2)Ended earlyNCT04240886
What this trial is testing

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica 21
Not applicableUnknownNCT04878796
What this trial is testing

Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV)

Who this might be right for
CancerCovid-19Vaccine Response
Azienda Socio Sanitaria Territoriale di Cremona 300
Large-scale testing (Phase 3)Ended earlyNCT04734873
What this trial is testing

CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients

Who this might be right for
Covid-19
Corvus Pharmaceuticals, Inc. 46
Not applicableStudy completedNCT05060562
What this trial is testing

Post Coronavirus Disease (COVID-19) Syndrome Indonesian Population

Who this might be right for
Covid19
Hasanuddin University 6,051
Not applicableUnknownNCT05381402
What this trial is testing

Impact of COVID 19 on Psoriasis Patients

Who this might be right for
The Impact of COVID19 on Psoriasis Patients
Cairo University 230
Not applicableActive Not RecruitingNCT05191446
What this trial is testing

Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use

Who this might be right for
Liver DiseasesAlcohol Use Disorder
University of California, San Francisco 180
Testing effectiveness (Phase 2)Study completedNCT04382586
What this trial is testing

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

Who this might be right for
COVID-19 Pulmonary ComplicationsCOVID-19
BeiGene 63
Not applicableActive Not RecruitingNCT05813873
What this trial is testing

The Use of Incentive Spirometry in Adult Patients Hospitalised in a Rehabilitation Center With Long-covid Syndrome

Who this might be right for
Long COVID
European University Cyprus 70
Large-scale testing (Phase 3)UnknownNCT04359303
What this trial is testing

Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients

Who this might be right for
COVID
Javier Hidalgo Tallón 50
Load More Results